FEBE Ventures Launches $75M Fund for Early-Stage Startups
FEBE Ventures, a Singapore-based venture capital firm, has launched its second fund worth USD 75 million. This new fund will focus on early-stage startups in B2B software, marketplaces, health, and sustainability sectors. The fund aims to support pre-seed and seed-level founders, marking an expansion from their inaugural USD 30 million fund.
The fund launch involves a strategic partnership with Silicon Valley-based Tekton Ventures to share expertise and resources. FEBE Ventures has also welcomed seasoned entrepreneurs Nicolas El Baze and Aditya Pendyala as partners to strengthen their team.
In other news, FEBE Ventures has successfully raised USD 75 million for their new fund, with notable partners including M Kapital, Raiffeisen Bank International, and Vorwerk. Meanwhile, Immensa has secured USD 20 million in a Series B funding round to transition into a global solutions provider and expand its presence. Fr8Labs, a Singapore-based logistics startup, has also raised USD 1.5 million in a seed funding round.
In the acquisition sphere, Catcha Digital has acquired a majority stake in Digital Symphony for MYR 21.17 million (USD 4.55 million). Keppel has strengthened its asset management capabilities in Europe by acquiring a 50% stake in Aermont Capital for SGD 517 million (USD 388.2 million). Rich Data Co has secured USD 17.5 million in a Series B funding round, with Westpac and nCino leading the investment.
The new FEBE Ventures fund, with its expanded focus and strategic partnerships, is set to make a significant impact on early-stage startups in key sectors. The successful fundraising and acquisitions, along with the growth of startups like Immensa and Fr8Labs, indicate a vibrant and dynamic investment landscape.
Read also:
- AI Validators: Unsung Heroes Ensuring Trust and Compliance
- GEW Demands Survey and Funding for Hessian Schools' Renovation
- India's Sports Revolution: Bhubaneswar, Chennai, and Ahmedabad Pioneering Nation's Athletic Makeover
- "Blood tests could potentially enhance the accuracy of malaria diagnoses in research circumstances"
